WallStSmart
ASTH

Astrana Health Inc

NASDAQ: ASTH · HEALTHCARE · MEDICAL CARE FACILITIES

$34.14
-2.50% today

Updated 2026-04-30

Market cap
$1.95B
P/E ratio
76.12
P/S ratio
0.61x
EPS (TTM)
$0.46
Dividend yield
52W range
$18 – $35
Volume
0.5M

Astrana Health Inc (ASTH) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+14.7%
Last 4 quarters
Revenue YoY growth
+42.9%
Most recent quarter
EPS YoY growth
+15.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+8.7%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+28.7%
2025-08-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-02$0.42+308.0%$20.33$24.51+20.6%
2025-11-06$0.01-97.9%$33.24$25.54-23.2%
2025-08-07$0.19-45.7%$21.81$28.08+28.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.10$0.42+308.0%$950.53M+42.9%
2025-09-30$0.47$0.01-97.9%$956.05M+99.7%
2025-06-30$0.35$0.19-45.7%$654.81M+34.7%
2025-03-31$0.33$0.34+2.5%$620.39M+53.4%
2024-12-31$0.21$0.37+71.8%$665.21M+88.4%
2024-09-30$0.32$0.33+3.1%$478.71M+37.5%
2024-06-30$0.39$0.40+2.6%$486.26M+39.6%
2024-03-31$0.30$0.31+3.3%$404.36M
2023-12-31$0.15$0.26+73.3%$353.04M
2023-09-30$0.33$0.47+42.4%$348.17M
2023-06-30$0.25$0.28+12.0%$348.21M

Frequently asked questions

Has Astrana Health Inc beaten earnings estimates?
Astrana Health Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +14.7% over the last 4 quarters.
How does ASTH stock react to earnings?
ASTH stock has moved an average of +8.7% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Astrana Health Inc's revenue growth rate?
Astrana Health Inc reported year-over-year revenue growth of +42.9% in its most recent quarter, with EPS growing +15.6% year-over-year.